Literature DB >> 26791223

Clemastine Enhances Myelination in the Prefrontal Cortex and Rescues Behavioral Changes in Socially Isolated Mice.

Jia Liu1, Jeffrey L Dupree2, Mar Gacias3, Rebecca Frawley3, Tamjeed Sikder3, Payal Naik3, Patrizia Casaccia3.   

Abstract

Altered myelin structure and oligodendrocyte function have been shown to correlate with cognitive and motor dysfunction and deficits in social behavior. We and others have previously demonstrated that social isolation in mice induced behavioral, transcriptional, and ultrastructural changes in oligodendrocytes of the prefrontal cortex (PFC). However, whether enhancing myelination and oligodendrocyte differentiation could be beneficial in reversing such changes remains unexplored. To test this hypothesis, we orally administered clemastine, an antimuscarinic compound that has been shown to enhance oligodendrocyte differentiation and myelination in vitro, for 2 weeks in adult mice following social isolation. Clemastine successfully reversed social avoidance behavior in mice undergoing prolonged social isolation. Impaired myelination was rescued by oral clemastine treatment, and was associated with enhanced oligodendrocyte progenitor differentiation and epigenetic changes. Clemastine induced higher levels of repressive histone methylation (H3K9me3), a marker for heterochromatin, in oligodendrocytes, but not neurons, of the PFC. This was consistent with the capability of clemastine in elevating H3K9 histone methyltransferases activity in cultured primary mouse oligodendrocytes, an effect that could be antagonized by cotreatment with muscarine. Our data suggest that promoting adult myelination is a potential strategy for reversing depressive-like social behavior. Significance statement: Oligodendrocyte development and myelination are highly dynamic processes influenced by experience and neuronal activity. However, whether enhancing myelination and oligodendrocyte differentiation is beneficial to treat depressive-like behavior has been unexplored. Mice undergoing prolonged social isolation display impaired myelination in the prefrontal cortex. Clemastine, a Food and Drug Administration-approved antimuscarinic compound that has been shown to enhance myelination under demyelinating conditions, successfully reversed social avoidance behavior in adult socially isolated mice. This was associated with enhanced myelination and oligodendrocyte differentiation in the prefrontal cortex through epigenetic regulation. Thus, enhancing myelination may be a potential means of reversing depressive-like social behavior.
Copyright © 2016 the authors 0270-6474/16/360957-06$15.00/0.

Entities:  

Keywords:  depression; epigenetics; myelination; prefrontal cortex; social isolation

Mesh:

Substances:

Year:  2016        PMID: 26791223      PMCID: PMC4719024          DOI: 10.1523/JNEUROSCI.3608-15.2016

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  23 in total

1.  Brief social defeat stress: long lasting effects on cocaine taking during a binge and zif268 mRNA expression in the amygdala and prefrontal cortex.

Authors:  Herbert E Covington; Takefumi Kikusui; Justin Goodhue; Ella M Nikulina; Ronald P Hammer; Klaus A Miczek
Journal:  Neuropsychopharmacology       Date:  2005-02       Impact factor: 7.853

2.  Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: a gene ontology study.

Authors:  Pavel Katsel; Kenneth L Davis; Vahram Haroutunian
Journal:  Schizophr Res       Date:  2005-09-01       Impact factor: 4.939

3.  Amygdala, hippocampal and corpus callosum size following severe early institutional deprivation: the English and Romanian Adoptees study pilot.

Authors:  Mitul A Mehta; Nicole I Golembo; Chiara Nosarti; Emma Colvert; Ashley Mota; Steven C R Williams; Michael Rutter; Edmund J S Sonuga-Barke
Journal:  J Child Psychol Psychiatry       Date:  2009-04-17       Impact factor: 8.982

4.  Antidepressant effect of optogenetic stimulation of the medial prefrontal cortex.

Authors:  Herbert E Covington; Mary Kay Lobo; Ian Maze; Vincent Vialou; James M Hyman; Samir Zaman; Quincey LaPlant; Ezekiel Mouzon; Subroto Ghose; Carol A Tamminga; Rachael L Neve; Karl Deisseroth; Eric J Nestler
Journal:  J Neurosci       Date:  2010-12-01       Impact factor: 6.167

5.  Muscarinic receptor subtypes as potential targets to modulate oligodendrocyte progenitor survival, proliferation, and differentiation.

Authors:  Federica De Angelis; Antonietta Bernardo; Valerio Magnaghi; Luisa Minghetti; Ada Maria Tata
Journal:  Dev Neurobiol       Date:  2012-05       Impact factor: 3.964

6.  Impaired adult myelination in the prefrontal cortex of socially isolated mice.

Authors:  Jia Liu; Karen Dietz; Jacqueline M DeLoyht; Xiomara Pedre; Dipti Kelkar; Jasbir Kaur; Vincent Vialou; Mary Kay Lobo; David M Dietz; Eric J Nestler; Jeffrey Dupree; Patrizia Casaccia
Journal:  Nat Neurosci       Date:  2012-11-11       Impact factor: 24.884

7.  Oligodendrocyte dysfunction in schizophrenia and bipolar disorder.

Authors:  Dmitri Tkachev; Michael L Mimmack; Margaret M Ryan; Matt Wayland; Tom Freeman; Peter B Jones; Michael Starkey; Maree J Webster; Robert H Yolken; Sabine Bahn
Journal:  Lancet       Date:  2003-09-06       Impact factor: 79.321

8.  Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder.

Authors:  C Aston; L Jiang; B P Sokolov
Journal:  Mol Psychiatry       Date:  2005-03       Impact factor: 15.992

9.  Differential rearing affects corpus callosum size and cognitive function of rhesus monkeys.

Authors:  M M Sánchez; E F Hearn; D Do; J K Rilling; J G Herndon
Journal:  Brain Res       Date:  1998-11-23       Impact factor: 3.252

10.  A myelin gene causative of a catatonia-depression syndrome upon aging.

Authors:  Nora Hagemeyer; Sandra Goebbels; Sergi Papiol; Anne Kästner; Sabine Hofer; Martin Begemann; Ulrike C Gerwig; Susann Boretius; Georg L Wieser; Anja Ronnenberg; Artem Gurvich; Stephan H Heckers; Jens Frahm; Klaus-Armin Nave; Hannelore Ehrenreich
Journal:  EMBO Mol Med       Date:  2012-04-04       Impact factor: 12.137

View more
  85 in total

1.  A novel myelin protein zero transgenic zebrafish designed for rapid readout of in vivo myelination.

Authors:  Marnie A Preston; Lisbet T Finseth; Jennifer N Bourne; Wendy B Macklin
Journal:  Glia       Date:  2019-01-09       Impact factor: 7.452

2.  Muscarinic Receptor M3R Signaling Prevents Efficient Remyelination by Human and Mouse Oligodendrocyte Progenitor Cells.

Authors:  R Ross Welliver; Jessie J Polanco; Richard A Seidman; Anjali K Sinha; Melanie A O'Bara; Zainab M Khaku; Diara A Santiago González; Akiko Nishiyama; Jurgen Wess; M Laura Feltri; Pablo M Paez; Fraser J Sim
Journal:  J Neurosci       Date:  2018-06-29       Impact factor: 6.167

Review 3.  Architecting the myelin landscape.

Authors:  Lindsay A Osso; Jonah R Chan
Journal:  Curr Opin Neurobiol       Date:  2017-07-11       Impact factor: 6.627

Review 4.  Emerging Role for Methylation in Multiple Sclerosis: Beyond DNA.

Authors:  Lindsay M Webb; Mireia Guerau-de-Arellano
Journal:  Trends Mol Med       Date:  2017-05-04       Impact factor: 11.951

5.  Changes in white matter in mice resulting from low-frequency brain stimulation.

Authors:  Denise M Piscopo; Aldis P Weible; Mary K Rothbart; Michael I Posner; Cristopher M Niell
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-18       Impact factor: 11.205

6.  Dysregulation of schizophrenia-related aquaporin 3 through disruption of paranode influences neuronal viability.

Authors:  Kazuo Kunisawa; Takeshi Shimizu; Itaru Kushima; Branko Aleksic; Daisuke Mori; Yasuyuki Osanai; Kenta Kobayashi; Anna M Taylor; Manzoor A Bhat; Akiko Hayashi; Hiroko Baba; Norio Ozaki; Kazuhiro Ikenaka
Journal:  J Neurochem       Date:  2018-08-29       Impact factor: 5.372

Review 7.  Remyelinating Pharmacotherapies in Multiple Sclerosis.

Authors:  Riley M Bove; Ari J Green
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

8.  Oligodendrocyte-Neuron Interactions: Impact on Myelination and Brain Function.

Authors:  Takeshi Shimizu; Yasuyuki Osanai; Kazuhiro Ikenaka
Journal:  Neurochem Res       Date:  2017-09-16       Impact factor: 3.996

Review 9.  Wrapped to Adapt: Experience-Dependent Myelination.

Authors:  Christopher W Mount; Michelle Monje
Journal:  Neuron       Date:  2017-08-16       Impact factor: 17.173

Review 10.  Remyelination Pharmacotherapy Investigations Highlight Diverse Mechanisms Underlying Multiple Sclerosis Progression.

Authors:  George S Melchor; Tahiyana Khan; Joan F Reger; Jeffrey K Huang
Journal:  ACS Pharmacol Transl Sci       Date:  2019-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.